In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


The Uterine Fibroid Market: High Growth for Uterus-Sparing Procedures

Executive Summary

In the treatment of uterine fibroids, there has historically been almost no middle ground between medical management by drugs with unpleasant side effects and the procedure of last resort, the hysterectomy. Now, though, a treatment landscape that's been barren for years, has finally become fertile ground for device innovation, according to a report published by Health Research International, "US Opportunities in the Management of Benign Uterine Conditions."

Related Content

In Rapidly-Growing MRI Field, Where's the Opportunity for Start-Ups?
GE'S Perception of Convergence
GE'S Perception of Convergence


Related Companies

Related Deals




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts